SmileDirectClub (SDC) Gets a Sell From Bank of America Securities
Analysts Have Conflicting Sentiments on These Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Alector (ALEC) and SmileDirectClub (SDC)
Bank of America Securities Remains a Sell on SmileDirectClub (SDC)
UBS Adjusts SmileDirectClub Price Target to $0.50 From $1.20, Maintains Neutral Rating
Loop Capital Upgrades SmileDirectClub to Hold From Sell, $1 Price Target